Orion Market Research (OMR) recently published a market research report on the Global Cardiac Ablation Market. According to OMR analysis, the Global Cardiac Ablation Market is estimated to rise with a significant CAGR during the forecast period (2017-2022). Cardiac ablation is the process that is used for the treatment of heart rhythm problems. Cardiac ablation destroys the tissues in the heart that triggers abnormal heart rhythm. Cardiac ablation generally uses catheters, which are inserted through arteries or vein in the body to deliver energy in the heart to modify the tissue that causes arrhythmia. Cardiac ablation can also be performed via open heart surgery, however, it is often done using catheters, which makes the procedure less invasive and reduces the recovery time. Increasing geriatric population, the rising prevalence of cardiovascular diseases are estimated to be the major factors that are augmenting the growth of the cardiac ablation market. Moreover, technological advancement in cardiac ablation and rise in the adoption of minimally invasive procedures with better medical imaging are also estimated to drive the growth of the cardiac ablation market.
A full report of the Global Cardiac Ablation Market is available at:
Furthermore, the Global Cardiac Ablation Market is segmented on the basis of technology and application. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Cardiac Ablation Market by Technology
- Cryoablation
- Electrical And Radiofrequency Ablation
- Microwave Ablation
- Ultrasound Ablation
2. Global Cardiac Ablation Market by Application
- Minimally Invasive Surgery
- Open Surgery
Visit here to know more about Cardiac Ablation Market study.
Region Covered
- North America (US and Canada)
- Europe (U K, Germany, France, Spain, and Italy)
- Asia-Pacific (China, India, South Korea, and Japan)
- Rest of the World (Middle East & Africa and Latin America)
Company Profile
- Ablacor
- Advanced Cardiac Therapeutics
- Angiodynamics
- Atricure Inc.
- Baren-Boym
- Biosense Webster
- Boston Scientific Corp.
- Conmed Corp.
- Ethicon
- Hansen Medical
- Hollister Inc.
- Medtronics Plc. (Covidien Ltd.)
- Mount Sinai Corporation
- Olympus Corporation
- St. Jude Medical Inc.
- Zenomed
For free sample request please visit: https://www.omrglobal.com/request-sample/?id=16838
The key objectives of the Cardiac Ablation Marketstudy:
- To analyze the Cardiac Ablation Market size (values and volume) by segments with historical data of 2017 and 2018 and forecast to 2025.
- To study the key factors influencing the growth of the market.
- Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
- To analyze the Cardiac Ablation Market growth, global trends, future prospectus and contribution to the market.
Related Reports:
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
No comments:
Post a Comment